The Australian regulator approved application of a vaccine of Pfizer, Inc from an omicron strain Koronavirus

The Australian management therapeutic goods (TGA) approved use of the adapted option of a vaccine from an omicron strain Koronavirus companies Pfizer, Inc for busterny vaccination of the population. About it it is reported in the statement of the regulator published on Monday, transfers Day.Az with reference to information agency "ITAR-TASS" ". TGA approved use of a bivalent vaccine against Koronavirus Comirnaty/Omicron BA.4-5 for busterny vaccination of persons at the age of 12 years and is more senior. It is the first vaccine from already approved TGA which is developed specially for prevention of BA.4 and BA.5 options an omicron strain", - it is specified in...